Related Experiment Video
Updated: Aug 7, 2026
16:19
Heterotopic Auxiliary Rat Liver Transplantation With Flow-regulated Portal Vein Arterialization in Acute Hepatic Failure
Published on: September 13, 2014
Lung transplantation for pulmonary hypertension
Seminars in Respiratory and Critical Care Medicine
|August 10, 2005
Summary
Lung transplantation is an option for severe pulmonary hypertension, but medical therapy can prolong life and may obviate the need for transplant. Careful patient selection and monitoring are key for optimal outcomes.
Area of Science:
- Cardiology
- Pulmonary Medicine
- Transplant Surgery
Background:
- Lung transplantation is a treatment for end-stage pulmonary hypertension but has significant risks.
- Limitations include infection, rejection, and reduced long-term survival, necessitating careful patient selection.
Purpose of the Study:
- To evaluate the role of medical therapy in managing pulmonary hypertension.
- To determine optimal timing for lung transplantation referral.
- To explore the complementary use of medical therapy and transplantation.
Main Methods:
- Review of current treatment options for pulmonary hypertension.
- Assessment of medical therapies including anticoagulation, diuretics, and vasodilators.
- Monitoring of patient response through exercise tolerance and hemodynamic parameters.
Main Results:
- Medical therapies like warfarin, diuretics, and vasodilators can prolong survival and potentially avoid transplantation.
- Unpredictable medication response and long transplant waiting times (1.5-2 years) impact treatment decisions.
- Symptomatic progression despite maximal medical therapy indicates need for transplant referral.
Conclusions:
- Lung transplantation should be reserved for patients failing maximal medical therapy.
- Medical therapy and transplantation should be used complementarily to improve quality of life and survival.
- Regular assessment of treatment response is crucial for managing pulmonary hypertension.
